APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multi-Omics Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Multi-Omics Service Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchMulti-Omics Service Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Multi-Omics Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Multi-Omics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multi-Omics Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Multi-Omics Service Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Multi-Omics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Multi-Omics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Multi-Omics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multi-Omics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Multi-Omics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Multi-Omics Service market include Metware, Genechem, Aptbiotech, Illumina, BGI, Singleronbio, Majorbio Group, Bioprofile and Dalton Bioanalytics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Multi-Omics Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Multi-Omics Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Multi-Omics Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Multi-Omics Service market.

Multi-Omics Service Segment by Company

Metware

Genechem

Aptbiotech

Illumina

BGI

Singleronbio

Majorbio Group

Bioprofile

Dalton Bioanalytics

Source BioScience

Psomagen

Biogenity

Sapient

Creative Biolabs

X-omics

RayBiotech

Sampled

Multi-Omics Service Segment by Type

Single-Cell Multi-omics

Spatial Multi-omics

Others

Multi-Omics Service Segment by Application

Cancer Research

Rare Disease Diagnostics

Drug Development

Crop Breeding

Microbiome Research

Others

Multi-Omics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Multi-Omics Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Multi-Omics Service key companies, revenue, market share, and recent developments.

3. To split the Multi-Omics Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Multi-Omics Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Multi-Omics Service significant trends, drivers, influence factors in global and regions.

6. To analyze Multi-Omics Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multi-Omics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multi-Omics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multi-Omics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Multi-Omics Service industry.

Chapter 3: Detailed analysis of Multi-Omics Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Multi-Omics Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Multi-Omics Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Multi-Omics Service Industry Trends Table 2. Multi-Omics Service Industry Drivers Table 3. Multi-Omics Service Industry Opportunities and Challenges Table 4. Multi-Omics Service Industry Restraints Table 5. Global Multi-Omics Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Multi-Omics Service Revenue Share by Company (2021-2026) Table 7. Global Multi-Omics Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Multi-Omics Service Key Company Manufacturing Base & Headquarters Table 9. Global Multi-Omics Service Company, Product Type & Application Table 10. Global Multi-Omics Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Multi-Omics Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single-Cell Multi-omics Table 15. Significant Companies of Spatial Multi-omics Table 16. Significant Companies of Others Table 17. Global Multi-Omics Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Multi-Omics Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Multi-Omics Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Multi-Omics Service Sales Value Share by Type (2021-2026) Table 21. Global Multi-Omics Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Cancer Research Table 23. Significant Companies of Rare Disease Diagnostics Table 24. Significant Companies of Drug Development Table 25. Significant Companies of Crop Breeding Table 26. Significant Companies of Microbiome Research Table 27. Significant Companies of Others Table 28. Global Multi-Omics Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Multi-Omics Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Multi-Omics Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Multi-Omics Service Sales Value Share by Application (2021-2026) Table 32. Global Multi-Omics Service Sales Value Share by Application (2027-2032) Table 33. Global Multi-Omics Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Multi-Omics Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Multi-Omics Service Sales Value Share by Region (2021-2026) Table 36. Global Multi-Omics Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Multi-Omics Service Sales Value Share by Region (2027-2032) Table 38. Global Multi-Omics Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Multi-Omics Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Multi-Omics Service Sales Value Market Share by Country (2021-2026) Table 41. Global Multi-Omics Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Multi-Omics Service Sales Value Market Share by Country (2027-2032) Table 43. Metware Company Information Table 44. Metware Business Overview Table 45. Metware Multi-Omics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Metware Multi-Omics Service Product Portfolio Table 47. Metware Recent Development Table 48. Genechem Company Information Table 49. Genechem Business Overview Table 50. Genechem Multi-Omics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Genechem Multi-Omics Service Product Portfolio Table 52. Genechem Recent Development Table 53. Aptbiotech Company Information Table 54. Aptbiotech Business Overview Table 55. Aptbiotech Multi-Omics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Aptbiotech Multi-Omics Service Product Portfolio Table 57. Aptbiotech Recent Development Table 58. Illumina Company Information Table 59. Illumina Business Overview Table 60. Illumina Multi-Omics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Illumina Multi-Omics Service Product Portfolio Table 62. Illumina Recent Development Table 63. BGI Company Information Table 64. BGI Business Overview Table 65. BGI Multi-Omics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. BGI Multi-Omics Service Product Portfolio Table 67. BGI Recent Development Table 68. Singleronbio Company Information Table 69. Singleronbio Business Overview Table 70. Singleronbio Multi-Omics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Singleronbio Multi-Omics Service Product Portfolio Table 72. Singleronbio Recent Development Table 73. Majorbio Group Company Information Table 74. Majorbio Group Business Overview Table 75. Majorbio Group Multi-Omics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Majorbio Group Multi-Omics Service Product Portfolio Table 77. Majorbio Group Recent Development Table 78. Bioprofile Company Information Table 79. Bioprofile Business Overview Table 80. Bioprofile Multi-Omics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bioprofile Multi-Omics Service Product Portfolio Table 82. Bioprofile Recent Development Table 83. Dalton Bioanalytics Company Information Table 84. Dalton Bioanalytics Business Overview Table 85. Dalton Bioanalytics Multi-Omics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Dalton Bioanalytics Multi-Omics Service Product Portfolio Table 87. Dalton Bioanalytics Recent Development Table 88. Source BioScience Company Information Table 89. Source BioScience Business Overview Table 90. Source BioScience Multi-Omics Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Source BioScience Multi-Omics Service Product Portfolio Table 92. Source BioScience Recent Development Table 93. Psomagen Company Information Table 94. Psomagen Business Overview Table 95. Psomagen Multi-Omics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Psomagen Multi-Omics Service Product Portfolio Table 97. Psomagen Recent Development Table 98. Biogenity Company Information Table 99. Biogenity Business Overview Table 100. Biogenity Multi-Omics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Biogenity Multi-Omics Service Product Portfolio Table 102. Biogenity Recent Development Table 103. Sapient Company Information Table 104. Sapient Business Overview Table 105. Sapient Multi-Omics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Sapient Multi-Omics Service Product Portfolio Table 107. Sapient Recent Development Table 108. Creative Biolabs Company Information Table 109. Creative Biolabs Business Overview Table 110. Creative Biolabs Multi-Omics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Creative Biolabs Multi-Omics Service Product Portfolio Table 112. Creative Biolabs Recent Development Table 113. X-omics Company Information Table 114. X-omics Business Overview Table 115. X-omics Multi-Omics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. X-omics Multi-Omics Service Product Portfolio Table 117. X-omics Recent Development Table 118. RayBiotech Company Information Table 119. RayBiotech Business Overview Table 120. RayBiotech Multi-Omics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. RayBiotech Multi-Omics Service Product Portfolio Table 122. RayBiotech Recent Development Table 123. Sampled Company Information Table 124. Sampled Business Overview Table 125. Sampled Multi-Omics Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Sampled Multi-Omics Service Product Portfolio Table 127. Sampled Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Multi-Omics Service Product Image Figure 2. Global Multi-Omics Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Multi-Omics Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Multi-Omics Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single-Cell Multi-omics Image Figure 8. Spatial Multi-omics Image Figure 9. Others Image Figure 10. Global Multi-Omics Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Multi-Omics Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Multi-Omics Service Sales Value Share by Type (2021-2032) Figure 13. Cancer Research Image Figure 14. Rare Disease Diagnostics Image Figure 15. Drug Development Image Figure 16. Crop Breeding Image Figure 17. Microbiome Research Image Figure 18. Others Image Figure 19. Global Multi-Omics Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Multi-Omics Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Multi-Omics Service Sales Value Share by Application (2021-2032) Figure 22. Global Multi-Omics Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Multi-Omics Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Multi-Omics Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America Multi-Omics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Multi-Omics Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Multi-Omics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Multi-Omics Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Multi-Omics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Multi-Omics Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America Multi-Omics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Multi-Omics Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Multi-Omics Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Multi-Omics Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Multi-Omics Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Multi-Omics Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Single-Cell Multi-omics
  • Spatial Multi-omics
  • Others
Applications
  • Cancer Research
  • Rare Disease Diagnostics
  • Drug Development
  • Crop Breeding
  • Microbiome Research
  • Others
Companies covered
  • Metware
  • Genechem
  • Aptbiotech
  • Illumina
  • BGI
  • Singleronbio
  • Majorbio Group
  • Bioprofile
  • Dalton Bioanalytics
  • Source BioScience
  • Psomagen
  • Biogenity
  • Sapient
  • Creative Biolabs
  • X-omics
  • RayBiotech
  • Sampled

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Multi-Omics Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Multi-Omics Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Multi-Omics Service Market Dynamics
  1. 2.1 Multi-Omics Service Industry Trends
  2. 2.2 Multi-Omics Service Industry Drivers
  3. 2.3 Multi-Omics Service Industry Opportunities and Challenges
  4. 2.4 Multi-Omics Service Industry Restraints
3 Multi-Omics Service Market by Company
  1. 3.1 Global Multi-Omics Service Company Revenue Ranking in 2025
  2. 3.2 Global Multi-Omics Service Revenue by Company (2021-2026)
  3. 3.3 Global Multi-Omics Service Company Ranking (2024-2026)
  4. 3.4 Global Multi-Omics Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Multi-Omics Service Company Product Type and Application
  6. 3.6 Global Multi-Omics Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Multi-Omics Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Multi-Omics Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Multi-Omics Service Market by Type
  1. 4.1 Multi-Omics Service Type Introduction
  2. 4.1.1 Single-Cell Multi-omics
  3. 4.1.2 Spatial Multi-omics
  4. 4.1.3 Others
  5. 4.2 Global Multi-Omics Service Sales Value by Type
  6. 4.2.1 Global Multi-Omics Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Multi-Omics Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Multi-Omics Service Sales Value Share by Type (2021-2032)
5 Multi-Omics Service Market by Application
  1. 5.1 Multi-Omics Service Application Introduction
  2. 5.1.1 Cancer Research
  3. 5.1.2 Rare Disease Diagnostics
  4. 5.1.3 Drug Development
  5. 5.1.4 Crop Breeding
  6. 5.1.5 Microbiome Research
  7. 5.1.6 Others
  8. 5.2 Global Multi-Omics Service Sales Value by Application
  9. 5.2.1 Global Multi-Omics Service Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Multi-Omics Service Sales Value by Application (2021-2032)
  11. 5.2.3 Global Multi-Omics Service Sales Value Share by Application (2021-2032)
6 Multi-Omics Service Regional Value Analysis
  1. 6.1 Global Multi-Omics Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Multi-Omics Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Multi-Omics Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Multi-Omics Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Multi-Omics Service Sales Value (2021-2032)
  7. 6.3.2 North America Multi-Omics Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Multi-Omics Service Sales Value (2021-2032)
  10. 6.4.2 Europe Multi-Omics Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Multi-Omics Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Multi-Omics Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Multi-Omics Service Sales Value (2021-2032)
  16. 6.6.2 South America Multi-Omics Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Multi-Omics Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Multi-Omics Service Sales Value Share by Country, 2025 VS 2032
7 Multi-Omics Service Country-level Value Analysis
  1. 7.1 Global Multi-Omics Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Multi-Omics Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Multi-Omics Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Multi-Omics Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Multi-Omics Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Multi-Omics Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Multi-Omics Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Multi-Omics Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Multi-Omics Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Multi-Omics Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Multi-Omics Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Multi-Omics Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Multi-Omics Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Multi-Omics Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Multi-Omics Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Multi-Omics Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Multi-Omics Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Multi-Omics Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Multi-Omics Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Multi-Omics Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Multi-Omics Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Multi-Omics Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Multi-Omics Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Multi-Omics Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Multi-Omics Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Multi-Omics Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Multi-Omics Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Multi-Omics Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Multi-Omics Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Multi-Omics Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Multi-Omics Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Multi-Omics Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Multi-Omics Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Multi-Omics Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Metware
  2. 8.1.1 Metware Company Information
  3. 8.1.2 Metware Business Overview
  4. 8.1.3 Metware Multi-Omics Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Metware Multi-Omics Service Product Portfolio
  6. 8.1.5 Metware Recent Developments
  7. 8.2 Genechem
  8. 8.2.1 Genechem Company Information
  9. 8.2.2 Genechem Business Overview
  10. 8.2.3 Genechem Multi-Omics Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Genechem Multi-Omics Service Product Portfolio
  12. 8.2.5 Genechem Recent Developments
  13. 8.3 Aptbiotech
  14. 8.3.1 Aptbiotech Company Information
  15. 8.3.2 Aptbiotech Business Overview
  16. 8.3.3 Aptbiotech Multi-Omics Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aptbiotech Multi-Omics Service Product Portfolio
  18. 8.3.5 Aptbiotech Recent Developments
  19. 8.4 Illumina
  20. 8.4.1 Illumina Company Information
  21. 8.4.2 Illumina Business Overview
  22. 8.4.3 Illumina Multi-Omics Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Illumina Multi-Omics Service Product Portfolio
  24. 8.4.5 Illumina Recent Developments
  25. 8.5 BGI
  26. 8.5.1 BGI Company Information
  27. 8.5.2 BGI Business Overview
  28. 8.5.3 BGI Multi-Omics Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BGI Multi-Omics Service Product Portfolio
  30. 8.5.5 BGI Recent Developments
  31. 8.6 Singleronbio
  32. 8.6.1 Singleronbio Company Information
  33. 8.6.2 Singleronbio Business Overview
  34. 8.6.3 Singleronbio Multi-Omics Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Singleronbio Multi-Omics Service Product Portfolio
  36. 8.6.5 Singleronbio Recent Developments
  37. 8.7 Majorbio Group
  38. 8.7.1 Majorbio Group Company Information
  39. 8.7.2 Majorbio Group Business Overview
  40. 8.7.3 Majorbio Group Multi-Omics Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Majorbio Group Multi-Omics Service Product Portfolio
  42. 8.7.5 Majorbio Group Recent Developments
  43. 8.8 Bioprofile
  44. 8.8.1 Bioprofile Company Information
  45. 8.8.2 Bioprofile Business Overview
  46. 8.8.3 Bioprofile Multi-Omics Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bioprofile Multi-Omics Service Product Portfolio
  48. 8.8.5 Bioprofile Recent Developments
  49. 8.9 Dalton Bioanalytics
  50. 8.9.1 Dalton Bioanalytics Company Information
  51. 8.9.2 Dalton Bioanalytics Business Overview
  52. 8.9.3 Dalton Bioanalytics Multi-Omics Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dalton Bioanalytics Multi-Omics Service Product Portfolio
  54. 8.9.5 Dalton Bioanalytics Recent Developments
  55. 8.10 Source BioScience
  56. 8.10.1 Source BioScience Company Information
  57. 8.10.2 Source BioScience Business Overview
  58. 8.10.3 Source BioScience Multi-Omics Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Source BioScience Multi-Omics Service Product Portfolio
  60. 8.10.5 Source BioScience Recent Developments
  61. 8.11 Psomagen
  62. 8.11.1 Psomagen Company Information
  63. 8.11.2 Psomagen Business Overview
  64. 8.11.3 Psomagen Multi-Omics Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Psomagen Multi-Omics Service Product Portfolio
  66. 8.11.5 Psomagen Recent Developments
  67. 8.12 Biogenity
  68. 8.12.1 Biogenity Company Information
  69. 8.12.2 Biogenity Business Overview
  70. 8.12.3 Biogenity Multi-Omics Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biogenity Multi-Omics Service Product Portfolio
  72. 8.12.5 Biogenity Recent Developments
  73. 8.13 Sapient
  74. 8.13.1 Sapient Company Information
  75. 8.13.2 Sapient Business Overview
  76. 8.13.3 Sapient Multi-Omics Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sapient Multi-Omics Service Product Portfolio
  78. 8.13.5 Sapient Recent Developments
  79. 8.14 Creative Biolabs
  80. 8.14.1 Creative Biolabs Company Information
  81. 8.14.2 Creative Biolabs Business Overview
  82. 8.14.3 Creative Biolabs Multi-Omics Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Creative Biolabs Multi-Omics Service Product Portfolio
  84. 8.14.5 Creative Biolabs Recent Developments
  85. 8.15 X-omics
  86. 8.15.1 X-omics Company Information
  87. 8.15.2 X-omics Business Overview
  88. 8.15.3 X-omics Multi-Omics Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 X-omics Multi-Omics Service Product Portfolio
  90. 8.15.5 X-omics Recent Developments
  91. 8.16 RayBiotech
  92. 8.16.1 RayBiotech Company Information
  93. 8.16.2 RayBiotech Business Overview
  94. 8.16.3 RayBiotech Multi-Omics Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 RayBiotech Multi-Omics Service Product Portfolio
  96. 8.16.5 RayBiotech Recent Developments
  97. 8.17 Sampled
  98. 8.17.1 Sampled Company Information
  99. 8.17.2 Sampled Business Overview
  100. 8.17.3 Sampled Multi-Omics Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sampled Multi-Omics Service Product Portfolio
  102. 8.17.5 Sampled Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst